Open
The DHA’s memorandum outlines compliance risks in the Therapeutic Products Bill 2022, urging member feedback to ensure balanced SaMD regulation that supports innovation and growth.
The DHA’s memorandum outlines compliance risks in the Therapeutic Products Bill 2022, urging member feedback to ensure balanced SaMD regulation that supports innovation and growth.